Understanding the pathology report of a prostate biopsy
/Many doctors will want to conduct a prostate specific antigen or PSA test on men once past the age of 40.
Read MoreMany doctors will want to conduct a prostate specific antigen or PSA test on men once past the age of 40.
Read MoreYet, for being two entirely different conditions, benign prostatic hyperplasia (BPH) and prostate cancer have a few similarities in common:
Read MoreProstate health is a primary focus all urologists want men to achieve. Yet prostate health is rarely on men’s health concerns radar.
Read MoreOne vital tool used to screen men for prostate cancer is PSA or prostate specific antigen testing.
Read MoreCall it an age thing. Benign prostatic hyperplasia (BPH) will be present in about one quarter of men by the time they reach the age of 55.
Read MoreA recent study of over 400,000 men under the age of 80 years found that prostate specific antigen (PSA) screening every 12 to 18 months decreased prostate cancer mortality and all-cause mortality risk by a significant 64% and 24% respectively, among men aged 55 to 74 years.
Read MoreDr David Samadi comments on a study finding MRI fusion biopsy outperforming standard prostate biopsy in patients with a prior negative prostate biopsy.
Read MoreIf a man is having symptoms of prostate cancer, the disease is most likely at an advanced stage. Symptoms possibly indicating prostate cancer all men should be aware of include the following:
Read MoreAll men need to have the talk – the talk with their male relatives on who has had prostate cancer or who has not.
Read MoreFrom lung cancer to breast cancer, all cancers have their own unique method of staging when cancer is found.
Read MoreEven though there is no proven prostate cancer prevention strategy, prevention is still the best medicine to practice.
Read MoreProstate cancer is the most common cancer in American men other than skin cancer. It affects about one in seven men and estimates for prostate cancer in the United States for 2018
Read More